Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13754)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 6, 2015 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hosseini-Carroll P, Mutyala M, Seth A, Nageeb S, Soliman D, Boktor M, Sheth A, Chapman J, Morris J, Jordan P, Manas K, Becker F, Alexander JS. Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management. World J Gastrointest Pharmacol Ther 2015; 6(4): 156-171 [PMID: 26558150 DOI: 10.4292/wjgpt.v6.i4.156] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v6/i4/156.htm |
| Number | Citing Articles |
| 1 |
Viviana Parra Izquierdo, Carolina Pavez Ovalle, Valeria Costa, Ana María Leguízamo, Juan Sebastián Frías Ordoñez, Albis Hani. Pregnancy and Inflammatory Bowel Disease: A Special Combination. Middle East Journal of Digestive Diseases 2023; 15(4): 222 doi: 10.34172/mejdd.2023.350
|
| 2 |
Bingxin Shi, Mangsuo Zhao, Tongchao Geng, Liyan Qiao, Yapeng Zhao, Xiuli Zhao. Effectiveness and safety of immunosuppressive therapy in neuromyelitis optica spectrum disorder during pregnancy. Journal of the Neurological Sciences 2017; 377: 72 doi: 10.1016/j.jns.2017.03.051
|
| 3 |
Amir Freud, Ofer Beharier, Asnat Walfisch, Ruslan Sergienko, Daniella Landau, Eyal Sheiner. Maternal Inflammatory Bowel Disease During Pregnancy is Not a Risk Factor for Long-term Morbidity of the Offspring. Journal of Crohn's and Colitis 2016; 10(11): 1267 doi: 10.1093/ecco-jcc/jjw083
|
| 4 |
Nahla A. Azzam, Abdulelah Almutairdi, Hajer Y. Almudaiheem, Turki AlAmeel, Shakir A. Bakkari, Othman R. Alharbi, Khalidah A. Alenzi, Maha A. AlMolaiki, Bedor A. Al-Omari, Rayan G. Albarakati, Ahmed H. Al-Jedai, Omar I. Saadah, Majid A. Almadi, Badr Al-Bawardy, Mahmoud H. Mosli. Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy. Saudi Journal of Gastroenterology 2023; doi: 10.4103/sjg.sjg_318_23
|
| 5 |
Priya Kathpalia, Sunanda Kane, Uma Mahadevan. Detectable Drug Levels in Infants Exposed to Biologics: So What?. Gastroenterology 2016; 151(1): 25 doi: 10.1053/j.gastro.2016.05.017
|
| 6 |
X. Cortes, J. Borrás-Blasco, B. Antequera, S. Fernandez-Martinez, E. Casterá, S. Martin, J. R. Molés. Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature. Journal of Clinical Pharmacy and Therapeutics 2017; 42(2): 234 doi: 10.1111/jcpt.12492
|
| 7 |
Entcho Klenske, Lourdes Osaba, Daniel Nagore, Timo Rath, Markus F Neurath, Raja Atreya. Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn’s Disease. Journal of Crohn's and Colitis 2019; 13(2): 267 doi: 10.1093/ecco-jcc/jjy153
|
| 8 |
Bincy P. Abraham, Tasneem Ahmed, Tauseef Ali. Gastrointestinal Pharmacology. Handbook of Experimental Pharmacology 2017; 239: 115 doi: 10.1007/164_2016_122
|
| 9 |
U. Mahadevan, S. Vermeire, K. Lasch, B. Abhyankar, F. Bhayat, A. Blake, M. Dubinsky. Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2017; 45(7): 941 doi: 10.1111/apt.13960
|
| 10 |
Agnieszka Kokoszko-Bilska, Slawomir Sobkiewicz, Jakub Fichna. Inflammatory bowel diseases and reproductive health. Pharmacological Reports 2016; 68(4): 859 doi: 10.1016/j.pharep.2016.03.009
|
| 11 |
Sule Poturoglu, Asli Ciftcibasi Ormeci, Ali Erkan Duman. Treatment of pregnant women with a diagnosis of inflammatory bowel disease. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(4): 490-502 doi: 10.4292/wjgpt.v7.i4.490
|
| 12 |
Nader D Daoud, Hassan Ghoz, Rachel Cannon, Jennifer A Farraye, Michael F Picco, Sunanda V Kane, Gursimran S Kochhar, Elisabeth J Woodhams, Francis A Farraye. Oral Contraceptive Pills Are an Effective Method of Preventing Pregnancy in Women With Crohn’s Disease. Crohn's & Colitis 360 2022; 4(1) doi: 10.1093/crocol/otab078
|
| 13 |
Rosemary E. Faulkes, Abhishek Chauhan, Ellen Knox, Tracey Johnston, Fiona Thompson, James Ferguson. Review article: chronic liver disease and pregnancy. Alimentary Pharmacology & Therapeutics 2020; 52(3): 420 doi: 10.1111/apt.15908
|
| 14 |
A.T. Hansen, R. Erichsen, E. Horváth‐Puhó, H.T. Sørensen. Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period. Journal of Thrombosis and Haemostasis 2017; 15(4): 702 doi: 10.1111/jth.13638
|
| 15 |
Bincy P Abraham, Elyssa Ott, Christopher Busse, Conor Murphy, Lindsay Miller, Daniel C Baumgart, Ellen Scherl, Christopher Gasink. Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn’s Disease and 2 Years in Ulcerative Colitis. Crohn's & Colitis 360 2022; 4(3) doi: 10.1093/crocol/otac025
|